SOLA Biosciences
Boston, US · Founded 2016 · 4 employees on LinkedIn · 3 known investors
Find your way into SOLA Biosciences
Sign up to see every warm intro you have to SOLA Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SOLA Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SOLA Biosciences is a preclinical-stage biopharmaceutical company developing gene therapies for neurodegenerative diseases like ALS, Huntington's Disease, and Alzheimer's Disease by targeting misfolded proteins. The company uses its proprietary JUMP70 platform to restore protein homeostasis and deliver disease-modifying treatments.
Founders & leadership
SOLA Biosciences was founded in 2016 by Keizo Koya and Akinori Hishiya.
KK

Keizo KoyaFounder and CEOKeizo Koya has spent over four decades in pharmaceutical research and development across the U.S. and Japan, with training in synthetic organic chemistry and biology. He has led drug development programs spanning oncology, neurodegeneration, autoimmune, and metabolic diseases across small molecules, biologics, and gene therapies, and has founded multiple biotech ventures.
Investors · 3
Frequently asked questions
- What does SOLA Biosciences do?
- SOLA Biosciences is a preclinical-stage biopharmaceutical company developing gene therapies for neurodegenerative diseases like ALS, Huntington's Disease, and Alzheimer's Disease by targeting misfolded proteins. The company uses its proprietary JUMP70 platform to restore protein homeostasis and deliver disease-modifying treatments.
- Who founded SOLA Biosciences?
- SOLA Biosciences was founded by Keizo Koya, Akinori Hishiya in 2016.
- Who are SOLA Biosciences's investors?
- SOLA Biosciences's investors include Eisai Innovation, Inc., MC Healthcare Ventures, UTEC.
- Where is SOLA Biosciences headquartered?
- SOLA Biosciences is headquartered in Boston, US.



